Cresemba (isavuconazole) — Blue Cross Blue Shield of Texas

Initial criteria

• ONE of the following: (a) diagnosis of invasive aspergillosis OR (b) diagnosis of invasive mucormycosis OR (c) another FDA labeled indication for the requested agent and route of administration OR (d) another indication supported in compendia for the requested agent and route of administration
• AND patient has no FDA labeled contraindications to the requested agent

Approval duration

6 months; Ohio Fully Insured/HIM Shop: 12 months